OpenURL Connection Search

Select item for more details and to access through your institution.

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer.
Published in:
Nature Communications, 2022, v. 11, n. 1, p. 1, doi. 10.1038/s41467-022-33172-5
By:
- Johnson, Radia M.;
- Qu, Xueping;
- Lin, Chu-Fang;
- Huw, Ling-Yuh;
- Venkatanarayan, Avinashnarayan;
- Sokol, Ethan;
- Ou, Fang-Shu;
- Ihuegbu, Nnamdi;
- Zill, Oliver A.;
- Kabbarah, Omar;
- Wang, Lisa;
- Bourgon, Richard;
- de Sousa e Melo, Felipe;
- Bolen, Chris;
- Daemen, Anneleen;
- Venook, Alan P.;
- Innocenti, Federico;
- Lenz, Heinz-Josef;
- Bais, Carlos
Publication type:
Article
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Published in:
Nature Medicine, 2007, v. 13, n. 9, p. 1070, doi. 10.1038/nm1627
By:
- Wagner, Klaus W.;
- Punnoose, Elizabeth A.;
- Januario, Thomas;
- Lawrence, David A.;
- Pitti, Robert M.;
- Lancaster, Kate;
- Lee, Dori;
- von Goetz, Melissa;
- Sharon Fong Yee;
- Totpal, Klara;
- Ling Huw;
- Katta, Viswanatham;
- Cavet, Guy;
- Hymowitz, Sarah G.;
- Amler, Lukas;
- Ashkenazi, Avi
Publication type:
Article
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples.
Published in:
Breast Cancer Research & Treatment, 2014, v. 148, n. 2, p. 315, doi. 10.1007/s10549-014-3163-8
By:
- Wilson, Timothy;
- Xiao, Yuanyuan;
- Spoerke, Jill;
- Fridlyand, Jane;
- Koeppen, Hartmut;
- Fuentes, Eloisa;
- Huw, Ling;
- Abbas, Ilma;
- Gower, Arjan;
- Schleifman, Erica;
- Desai, Rupal;
- Fu, Ling;
- Sumiyoshi, Teiko;
- O'Shaughnessy, Joyce;
- Hampton, Garret;
- Lackner, Mark
Publication type:
Article
Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 504, doi. 10.1016/j.clml.2021.12.014
By:
- Palomba, Maria Lia;
- Cartron, Guillaume;
- Popplewell, Leslie;
- Ribrag, Vincent;
- Westin, Jason;
- Huw, Ling-Yuh;
- Agarwal, Shefali;
- Shivhare, Mahesh;
- Hong, Wan-Jen;
- Raval, Aparna;
- Chang, Alice C.;
- Penuel, Elicia;
- Morschhauser, Franck
Publication type:
Article
ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S393, doi. 10.1016/S2152-2650(21)01892-9
By:
- Budde, Elizabeth;
- Ghosh, Nilanjan;
- Chavez, Julio;
- Lossos, Izidore S.;
- Mehta, Amitkumar;
- Dorritie, Kathleen;
- Kamdar, Manali;
- Negricea, Raluca;
- Song Pham;
- Hristopoulos, Maria;
- Ling-Yuh Huw;
- OHear, Carol;
- Yasuhiro Oki;
- To, Iris;
- Diefenbach, Catherine
Publication type:
Article
Poster: ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S241, doi. 10.1016/S2152-2650(21)01516-0
By:
- Budde, Elizabeth;
- Ghosh, Nilanjan;
- Chavez, Julio;
- Lossos, Izidore S.;
- Mehta, Amitkumar;
- Dorritie, Kathleen;
- Kamdar, Manali;
- Negricea, Raluca;
- Song Pham;
- Hristopoulos, Maria;
- Ling-Yuh Huw;
- O'Hear, Carol;
- Yasuhiro Oki;
- To, Iris;
- Diefenbach, Catherine
Publication type:
Article
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.
Published in:
NPJ Precision Oncology, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41698-018-0051-4
By:
- Wagle, Marie-Claire;
- Kirouac, Daniel;
- Klijn, Christiaan;
- Liu, Bonnie;
- Mahajan, Shilpi;
- Junttila, Melissa;
- Moffat, John;
- Merchant, Mark;
- Huw, Ling;
- Wongchenko, Matthew;
- Okrah, Kwame;
- Srinivasan, Shrividhya;
- Mounir, Zineb;
- Sumiyoshi, Teiko;
- Haverty, Peter M.;
- Yauch, Robert L.;
- Yan, Yibing;
- Kabbarah, Omar;
- Hampton, Garret;
- Amler, Lukas
Publication type:
Article
PROMISING CLINICAL DATA FROM DOSE ESCALATION IN A PHASE IB/II ONGOING STUDY OF MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN FOR RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.154_2880
By:
- Diefenbach, C;
- Budde, E;
- Chavez, J;
- Lossos, I. S;
- Mehta, A;
- Dorritie, K;
- Kamdar, M;
- Negricea, R;
- Pham, S;
- Hristopoulos, M;
- Huw, Ling-Y;
- Hear, C. O;
- Oki, Y;
- To, I;
- Ghosh, N
Publication type:
Article
Systems‐based digital twins to help characterize clinical dose–response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHL.
Published in:
CTS: Clinical & Translational Science, 2023, v. 16, n. 7, p. 1134, doi. 10.1111/cts.13501
By:
- Susilo, Monica E.;
- Li, Chi‐Chung;
- Gadkar, Kapil;
- Hernandez, Genevive;
- Huw, Ling‐Yuh;
- Jin, Jin Y.;
- Yin, Shen;
- Wei, Michael C.;
- Ramanujan, Saroja;
- Hosseini, Iraj
Publication type:
Article
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
Published in:
2016
By:
- Makker, Vicky;
- Recio, Fernando O.;
- Ma, Ling;
- Matulonis, Ursula A.;
- Lauchle, Jennifer O.;
- Parmar, Hema;
- Gilbert, Houston N.;
- Ware, Joseph A.;
- Zhu, Rui;
- Lu, Shan;
- Huw, Ling-Yuh;
- Wang, Yulei;
- Koeppen, Hartmut;
- Spoerke, Jill M.;
- Lackner, Mark R.;
- Aghajanian, Carol A.
Publication type:
journal article

Found: 10